drugset
Drugs / Mirodenafil
last change Dec 2014 re-read 9 days ago

Mirodenafil

also known as SK3530 · Mirodenafilo · SK-3530 FREE BASE

Small molecule

Developed for
erectile dysfunction · hypertensive disorder
Investigated by
SK Chemicals Co., Ltd. · Asan Medical Center

Trials 10

today NCT02485041 · Ph 1 NCT02485028 · Ph 1 NCT01232010 · Ph 1 NCT00626743 · Ph 1 NCT00644007 · Ph 3 NCT00705861 · Ph 3 NCT00489606 · Ph 1 NCT00489450 · Ph 1 NCT00443625 · Ph 1 NCT00351065 · Ph 2
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 17 trials
Phase 1 NCT02485041 Nov → Dec 2014 — SK Chemicals Co., Ltd. Completed No outcome recorded
Phase 1 NCT02485028 Oct → Nov 2013 — SK Chemicals Co., Ltd. Completed No outcome recorded
Phase 1 NCT01232010 Nov 2009 → Dec 2011 impaired renal function disease Asan Medical Center Completed No outcome recorded
Phase 1 NCT00626743 May 2008 → May 2009 hypertensive disorder SK Chemicals Co., Ltd. Completed No outcome recorded
Phase 1 NCT00489606 Apr → Jun 2007 erectile dysfunction SK Chemicals Co., Ltd. Completed No outcome recorded
Phase 1 NCT00489450 Mar → May 2007 erectile dysfunction SK Chemicals Co., Ltd. Completed No outcome recorded
Phase 1 NCT00443625 Dec 2006 → Feb 2007 erectile dysfunction SK Chemicals Co., Ltd. Completed No outcome recorded
Phase 21 trial
Phase 2 NCT00351065 Sep 2004 → Mar 2005 erectile dysfunction SK Chemicals Co., Ltd. Terminated No outcome recorded
Phase 32 trials
Phase 3 NCT00644007 Dec 2007 → Sep 2008 erectile dysfunction SK Chemicals Co., Ltd. Completed No outcome recorded
Phase 3 NCT00705861 Nov 2007 → Jul 2008 erectile dysfunction SK Chemicals Co., Ltd. Completed No outcome recorded

Evidence & citations 7 cited values

Every value below carries the sentence it was read from. 11 sources stand behind the page.

FieldValueCited text
Known as Mirodenafil ClinicalTrials.gov intervention name — accepted as the source's own label NCT01232010 ↗
2

NCT02485028 ↗

NCT02485041 ↗
Known as Mirodenafilo ChEMBL registry synonym — accepted as the source's own label CHEMBL4297518 ↗
Known as SK-3530 FREE BASE ChEMBL registry synonym — accepted as the source's own label CHEMBL4297518 ↗
Known as SK3530 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00626743 ↗
6

NCT00489606 ↗

NCT00489450 ↗

NCT00705861 ↗

NCT00443625 ↗

NCT00644007 ↗

NCT00351065 ↗
Action Inhibit “The PDE5 inhibitor, SK3530, is expected to be taken concomitantly with food.” NCT00443625 ↗
Modality Small molecule — CHEMBL4297518 ↗
Route Oral “after oral administration” NCT00351065 ↗